Listen
ERBITUX
Cancérologie - Nouvelle indication
Opinions on drugs -
Posted on
Jan 06 2011
Reason for request
Inclusion on the list of medicines approved for hospital use in the extension of indication: "ERBITUX is indicated for the treatment of patients with squamous cell cancer of the head and neck in combination with platinum-based chemotherapy for recurrent and/or metastatic disease".
-
Clinical Benefit
| Substantial |
- |
Clinical Added Value
| moderate |
- |
English version
Contact Us
Évaluation des médicaments
